Eli Lilly and Co (LLY)
747.82
-2.10
(-0.28%)
USD |
NYSE |
Nov 22, 16:00
747.50
-0.32
(-0.04%)
After-Hours: 18:42
Eli Lilly Free Cash Flow: -2.275B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.275B |
| June 30, 2024 | -3.628B |
| March 31, 2024 | -3.896B |
| December 31, 2023 | -3.152B |
| September 30, 2023 | -164.90M |
| June 30, 2023 | 3.211B |
| March 31, 2023 | 3.786B |
| December 31, 2022 | 4.600B |
| September 30, 2022 | 5.339B |
| June 30, 2022 | 4.950B |
| March 31, 2022 | 5.824B |
| December 31, 2021 | 5.388B |
| September 30, 2021 | 4.621B |
| June 30, 2021 | 4.837B |
| March 31, 2021 | 5.565B |
| December 31, 2020 | 4.470B |
| September 30, 2020 | 5.112B |
| June 30, 2020 | 4.890B |
| March 31, 2020 | 3.684B |
| December 31, 2019 | 3.483B |
| September 30, 2019 | 2.671B |
| June 30, 2019 | 3.324B |
| March 31, 2019 | 2.217B |
| December 31, 2018 | 2.506B |
| September 30, 2018 | 2.931B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.543B |
| March 31, 2018 | 4.313B |
| December 31, 2017 | 3.452B |
| September 30, 2017 | 3.744B |
| June 30, 2017 | 3.744B |
| March 31, 2017 | 3.472B |
| December 31, 2016 | 3.759B |
| September 30, 2016 | 2.659B |
| June 30, 2016 | 2.006B |
| March 31, 2016 | 1.438B |
| December 31, 2015 | 1.338B |
| September 30, 2015 | 1.570B |
| June 30, 2015 | 2.138B |
| March 31, 2015 | 2.349B |
| December 31, 2014 | 2.892B |
| September 30, 2014 | 3.400B |
| June 30, 2014 | 3.789B |
| March 31, 2014 | 4.490B |
| December 31, 2013 | 4.642B |
| September 30, 2013 | 4.612B |
| June 30, 2013 | 4.202B |
| March 31, 2013 | 3.794B |
| December 31, 2012 | 4.261B |
| September 30, 2012 | 4.770B |
| June 30, 2012 | 5.167B |
Free Cash Flow Range, Past 5 Years
-3.896B
Minimum
Mar 2024
5.824B
Maximum
Mar 2022
2.832B
Average
4.535B
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Biogen Inc | 1.768B |
| Johnson & Johnson | 19.02B |
| Viking Therapeutics Inc | -74.25M |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.712B |
| Cash from Investing (Quarterly) | -4.005B |
| Cash from Financing (Quarterly) | 211.30M |
| Free Cash Flow Per Share (Quarterly) | -0.5071 |
| Free Cash Flow to Equity (Quarterly) | -2.687B |
| Free Cash Flow to Firm (Quarterly) | -370.39M |
| Free Cash Flow Yield | -0.34% |